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Background: Guibi-Tang is a traditional herbal prescription made from 12 different herbs that is used in the
treatment of amnesia and poor memory.
Methods: In the present study, we evaluated the acute oral toxicity and genotoxic potential of Guibi-Tang water
extract (GBT) at doses up to 2000 μg/plate an using a bacterial reverse mutation test (Ames test) with Salmonella
typhimurium strains TA100, TA1535, TA98, and TA1537, and Escherichia coli strain WP2uvrA. Acute toxicity and
genotoxic potential were measured in the presence and absence of an exogenous source of metabolic activation,
in an in vitro chromosome aberration assay with Chinese hamster lung (CHL) cells, and in an in vivo micronucleus
test using ICR mice bone marrow as recommended by the Korean Food and Drug Administration. An acute oral
toxicity test of GBT was performed in Sprague Dawley rats. The Ames test showed that GBT did not induce gene
mutations in S. typhimurium or in E. coli in the presence or absence of S9 activation.
Results: GBT did not significantly increase the number of structural aberrations in CHL cells with or without S9
activation. The oral administration of GBT at a dose of up to 2000 mg/kg caused no significant increase in the
number of micronucleated polychromatic erythrocytes or in the mean ratio of polychromatic to total erythrocytes.
Conclusions: However, as we did not identify the components of GBT responsible for these effects, other assays
are needed to confirm its genotoxicity.
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Traditional herbal medicines are selected to accentuate
the therapeutic activity of their components while redu-
cing the toxicity or side effects of compounds from other
herbal species in the mixture [1].
The traditional herbal medicine Guibi-Tang (known
as Qui-Pi-Tang in Chinese and Kihi-To in Japanese) is a
mixture of 12 herbal preparations (Angelicae Gigantis
Radix, Longan Arillus, Zizyphi Semen, Polygalae Radix,
Ginseng Radix Alba, Astragali Radix, Atractylodis
Rhizoma Alba, Hoelen Cum Radix, Aucklandiae Radix,* Correspondence: hkshin@kiom.re.kr
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unless otherwise stated.Glycyrrhizae Radix, Zingiberis Rhizoma Crudus, and
Zizyphi Fructus) [2]. This mixture has long been used
to treat amnesia, poor memory or forgetfulness, fatigue,
insomnia, anemia, palpitation, and neurosis.
Guibi-Tang has several pharmacological effects such as
upregulation of choline acetyltransferase activity in rat
embryo septal cultures [3]. Administration of Guibi-Tang
for 3 months was reported to improve the scores on the
Mini-Mental State Examination in 25 patients with senile
dementia [4]. Although Guibi-Tang is used in the treat-
ment of amnesia and its therapeutic efficacy has been
studied, its toxicity remains unclear. Despite the popular
use of centaury in traditional herbal medicine, no system-
atic evaluation of its genotoxic effects has been performed.
Assessment of the genotoxic properties of folk medicine is. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to critical mutations and may thereby increase the risk
of diseases including cancer [5]. The aim of the present
study was to evaluate the safety of an aqueous extract
of Guibi-Tang (GBT) and its potential genotoxicity. We
assessed these properties using the standard battery of
tests recommended by the Korea Food and Drug Admin-
istration: a bacterial reverse mutation test (Ames test),
chromosome aberration test, and in vivo micronucleus test.
Methods
Preparation of GBT
The twelve crude herbs of GBT were purchased from
Kwangmyungdang Medicinal herbs (Ulsan, Korea). The
origin of each herbal medicine was taxonomically
confirmed by Prof. Je Hyun Lee, Dongguk University,
Gyeongju, Korea. Voucher specimens (2012-KE22-1
through KE22-12) have been deposited at the Herbal
Medicine Formulation Research Group, Korea Institute
of Oriental Medicine. A decoction of GBT was pre-
pared in our laboratory from a mixture of chopped
crude herbs (Table 1), and GBT was extracted in dis-
tilled water at 100°C for 2 h. The solution was evapo-
rated to dryness and freeze-dried (yield: 22.9%). The
extracted GBT powder was stored at 4°C.
HPLC analysis of GBT
HPLC simultaneous determination was performed using a
Shimadzu LC-20A HPLC system (Shimadzu Co., Kyoto,
Japan), consisting of LC-20AT pump, DGU-20A3 online
degasser, SPD-M20A detector, SIL-20 AC auto-sampler,
and CTO-20A column oven. The data processor employed
LC solution software (Version 1.24). The separation of
three compounds was conduct using a Gemini C18 (250 ×
4.6 mm; 5 μm, Phenomenex, Torrance, CA, USA) andTable 1 The combination of crude components of Guibi-Tang
Herbal name Scientific name Amount
Angelicae Gigantis Radix Angelica gigas 3.75
Longan Arillus Dimocarpus longan 3.75
Ziayphi Semen Ziayphus jujuba 3.75
Polygalae Radix Polygala tenuifolia 3.75
Ginseng Radix Alba Panax ginseng 3.75
Astragali Radix Astragalus membranaceus 3.75
Atractylodis Rhizoma Alba Atractylodes japonica 3.75
Hoelen Cum Radix Poria cocos 3.75
Aucklandiae Radix Aucklandia lappa 1.875
Glycyrrhizse Radix Glycyrrhiza uralensis 1.125
Zingiberis Rhizoma Crudus Zingiber officinale 6.25
Zizyphi Fructus Zizyphus jujuba 3.75
Total 35.625column oven temperature was maintained at 40°C. The
mobile phases were composed of 1.0% (v/v) aqueous acetic
acid (A) and 1.0% (v/v) acetic acid in acetonitrile (B). The
gradient condition was as follows: 0–30 min, 10–70%
B; 30–35 min, 70–100% B; 35–40 min, 100–100% B;
40–45 min, 100–10% B; 45–60 min, 10–10% B. The
analysis was conduct at a flow-rate of 1.0 mL/min with
PDA detection at 254 nm, 280 nm, and 330 nm. The
injection volume was 10 μL.
The three compounds in GBT were well separated
using the developed HPLC method. The retention times
of the three major components under the optimized
HPLC assay were 14.23, 15.16, and 29.07 min for liquiri-
tin, nodakenin, and glycyrrhizin, respectively. The amount
of three quantify compounds in GBT included 0.70 ±
0.01 mg/g (liquiritin), 0.03 ± 0.01 mg/g (glycyrrhizin), and
1.43 ± 0.01 mg/g (nodakenin), which are components of
Glycyrrhizae Radix et Rhizoma and Angelicae Gigantis
Radix, respectively.
Acute oral toxicity test
To test the acute oral toxicity, specific pathogen-free
Sprague Dawley rats of both sexes were obtained at 5 weeks
of age from Orient Bio Co., Ltd. (Seongnam, Korea) and
used after 1 week of quarantine and acclimatization. This
study was approved by the Korea Institute of Oriental
Medicine Institutional Animal Care and Use Committee,
was performed at the Korea Institute of Toxicology
(Daejeon, Republic of Korea), and was conducted ac-
cording to the guidelines of the Institutional Animal Care
and Use Committee in the Korea Institute of Toxicology,
which is accredited by AAALAC International (1998)
under the GLP Regulations for Nonclinical Laboratory
Studies. A preliminary study showed that a single oral
administration of GBT did not induce any toxic effect atextract
(g) Company of purchase Source
Kwangmyungdang Medicinal herbs Yeongcheon, Korea
Kwangmyungdang Medicinal herbs Vietnam
Kwangmyungdang Medicinal herbs China
Kwangmyungdang Medicinal herbs China
Kwangmyungdang Medicinal herbs Geumsan, Korea
Kwangmyungdang Medicinal herbs Jeongseon, Korea
Kwangmyungdang Medicinal herbs China
Kwangmyungdang Medicinal herbs China
Kwangmyungdang Medicinal herbs China
Kwangmyungdang Medicinal herbs China
Kwangmyungdang Medicinal herbs Yeongcheon, Korea
Kwangmyungdang Medicinal herbs Yeongcheon, Korea
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results, a dose of 2000 mg/kg/day was selected as the
toxicological limited dose recommended by the OECD
guidelines. Healthy male and female rats were assigned
to groups of five rats of each sex. GBT was suspended
in distilled water, and the volume for application of
a dose of 10 mL/kg body weight was calculated. The
vehicle control rats received an equivalent volume of
distilled water only. All animals were observed, and
mortality, clinical signs, body weight changes, and gross
findings were recorded for 14 days.
Preparation of the S9 mixture
The two in vitro genotoxicity tests were conducted in
compliance with the OECD guidelines for the testing of
chemicals (July 21, 1997) in the publications TG No. 473
‘In vitro Mammalian Chromosome Aberration Test’ and
TG No. 471 ‘Bacterial Reverse Mutation Test’ with and
without metabolic activation (OECD guidelines TG 473
and TG 471, 1997).
Rat liver microsomal enzyme (S9) prepared male
Sprague–Dawley rats induced with Aroclor 1254, was
obtained from Molecular Toxicology Inc. (Boon, NC,
USA). Before the experiment, an appropriate quantity of
S9 supernatant was thawed and mixed with S9 cofactor
solution. The amount of S9 supernatant was 10% v/v in
the S9 mixture. Cofactors were added to the S9 mixture to
reach the final concentrations of 8 mM MgCl2, 33 mM
KCl, 5 mM glucose-6-phosphate, and 5 mM NADP in
the S9 mixture.
Bacterial reverse mutation assay (Ames test)
The experimental methods used in the study were based
on the published reports by Maron and Ames [6] with
minor modifications. Salmonella typhimurium strains TA98
and TA1537 (to detect frame-shift mutagens), TA100, and
TA1535, and Escherichia coli strain WP2uvrA (to detect
base pair-substitution mutagens) were obtained from
Molecular Toxicology Inc. (Boone, NC, USA) and were
used as the tester strains. To evaluate the toxicity and
solubility (precipitation) of GBT, a pilot experiment was
performed with all bacterial strains. GBT was dissolved in
distilled water. The positive control factors were dissolved
in either distilled water or DMSO and stored at −20°C;
these positive control factors were 2-nitrofluorene (2-NF),
2-aminoanthracene (2-AA), 9-aminoacridine (9-AA),
4-nitroquinoline X-oxide (4NQO), and benzo (a) pyrene
(BP). A dose range-finding test was performed to deter-
mine the highest concentration for the present study,
which was performed with the five tester strains at con-
centrations of 625, 1250, 2500, and 5,000 μg/plate with
and without the S9 mixture. The number of revertant
colonies did not increase to more than twice the value
observed in the controls for any of the tester stains.However, there were increased numbers of revertant
colonies of TA1535 with the S9 mixture. Based on these
results, a dose of 5,000 μg/plate was selected as the
maximum dose.
Briefly, various concentrations of GBT were incubated
with the tester strains at 37°C for 48 h in the presence
or absence of metabolic activation by the S9 mixture
along with vehicle and positive controls containing the
following combinations of substances and doses: 2-AA
at 2 μg/plate vs. TA1535 with or without the S9 mixture
and at 4 μg/plate vs. WP2uvrA with the S9 mixture; 9-AA
at 50 μg/plate vs. TA1537 without the S9 mixture; BP
at 2 μg/plate vs. TA98 with or without the S9 mixture
and vs. TA100 and TA1537 with the S9 mixture); 2-NF
at 2 μg/plate vs. TA98 without the S9 mixture; 4NQO
at 0.5 μg/plate vs. WP2uvrA without the S9 mixture;
and sodium azide at 0.5 μg/plate vs. TA100 and
TA1535 without the S9 mixture. Each concentration of
GBT was tested in triplicate. A result was deemed posi-
tive if there was a concentration-related increase over
the range tested and/or a reproducible increase at one
or more concentrations in the number of revertant
colonies per plate in at least one strain with or without
the S9 mixture. An antibacterial effect (cytotoxicity)
was defined as a clearing or diminution of the back-
ground lawn, the appearance of microcolonies, and/or
a decrease of > 50% in the number of colonies com-
pared with the relevant vehicle control.
Chromosome aberration test
Chinese hamster lung (CHL) cells were obtained from
American Type Culture Collection (Manassas, VA, USA)
in 2004. The cells were thawed in culture medium and
then grown for more than 7 days as a monolayer. Cells
were cultured in reconstituted MEM (Gibco-Invitrogen,
USA) supplemented with 2.2 g of sodium bicarbonate,
292 mg of L-glutamine, streptomycin sulfate (100 μg/
mL), penicillin G · Na (105 units), and 10% (v/v) fetal bo-
vine serum (FBS; Gibco-Invitrogen, USA) per liter. The
cultures were incubated at 37°C in a humidified atmos-
phere with 1.5% CO2. A preliminary dose range-finding
study was performed to determine the highest concen-
tration for this study. Using the results from the dose
range-finding study, the dose range for the present study
was designed to quantify the solubility and cytotoxicity
of GBT. Ethyl methanesulfonate (EMS) was used as a
positive control substance without metabolic activation
and cyclophosphamide (CPA) with metabolic activation.
Cells were trypsinized and counted, and the relative cell
count (RCC) was calculated. The cells were centrifuged
at ~1000 rpm for 5 min and resuspended in 5 mL of
75 mM KCl solution. After 10 min at room temperature,
5 mL of fixative (methanol:glacial acetic acid = 3:1 v/v)
was added to the cell suspension, and the suspension was
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by centrifugation at ~1500 rpm for 5 min. Two slides were
prepared from each fixed-cell suspension. The slides were
air-dried, stained with 3% Giemsa solution, washed in tap
water and distilled water, dried, and mounted in DPX
(Fluka) for chromosome aberration scoring.
Chromosome aberrations were identified morphologically
according to the principles described in the ‘Atlas of
chromosome aberration by chemicals’ (JEMS-MMS, 1988).
Cells with more than four of the same type of aberration
were scored as multiple aberrations. Any metaphase with
one or more aberrations, regardless of the type, was classi-
fied as an aberration metaphase. Slides were scanned sys-
temically, and each set of metaphases was examined at
1000× magnification. Structural chromosome aberrations
were evaluated in 100 well-spread metaphases, each con-
taining 23 to 27 chromosomes. The microscopic stage
coordinates and each type and number of aberration
were recorded for each aberrant metaphase. The results
are expressed as the number of findings per 100 meta-
phases. Regardless of the presence of aberrations, an add-
itional 100 metaphases were examined to determine the
frequency of diploidy (DP), polyploidy (PP, > 37 chromo-
somes), and endoreduplication (ER).
In vivo micronucleus test
The preliminary study showed that oral administration
of GBT at a dose of 2000 mg/kg did not induce any toxic
effect. The highest dose was determined based on the
dose range-finding study, and 2000 mg/kg, which wasFigure 1 Mean body weight changes after administrated with GBT
presented as mean ± SD.the limit dose for treatment up to 14 days according
to the OECD guidelines, was selected as the maximum
dose. Specific pathogen-free male CrljOri:CD1 (ICR) mice
weighing 27.2–30.0 g were obtained from Orient Bio
Co., Ltd. (Seongnam, Korea) at 6 weeks of age. Mice
were used in experiments after 1 week of quarantine and
acclimatization. This study was reviewed and assessed by
the IACUC of the Korea Institute of Toxicology. All
animals were cared for in accordance with the principles
outlined in the NIH Guide for the Care and Use of
Laboratory Animals (AAALAC International accredited
in 1998). GBT was administered once a day for 2 days by
gavage to male ICR mice. The positive control was CPA
monohydrate in normal saline (10 mL/kg), which was
given at a dose of 70 mg/kg i.p. just before the dose on the
second day of dosing [7].
Animals were sacrificed by CO2 gas inhalation at ~24 h
after the final administration, and bone marrow prepara-
tions were made using the method of Schmid [8].
Two slides of the cell suspension from each animal
were made. Small round or oval bodies, measuring about
1/5 to 1/20 the diameter of a polychromatic erythrocyte
(PCE), were counted as micronuclei. The same observer
scored a total of 2000 PCEs per animal to determine the
frequency of micronucleated polychromatic erythrocytes
(MNPCEs). The ratio of PCEs to normochromatic eryth-
rocytes (NCE) [PCE/(PCE +NCE) ratio] was calculated
by counting 500 cells. The mortality and external ap-
pearance of animals were checked and recorded once a
day during the study period, and these observations wereat dose levels of 0 (vehicle) and 2000 mg/kg/day. Values are
Figure 2 Effect of GBT on bacterial reverse mutation assay (Ames test) (A) with (+S9 mix) and (B) without (−S9 mix) metabolic activation.
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final dosing day. Body weight was measured on the days
of reception, grouping, dosing, and autopsy.
Statistical analyses
The statistical analyses used for the study were selected
based on the methods used in published reports [9]
using SAS software (version 9.1.3, SAS Institute Inc.,
Cary, NC, USA). Each metaphase was classified as a nor-
mal metaphase or aberrant metaphase with one or more
aberrations, and the frequency of aberrant metaphase
was analyzed statistically. The numerical aberrations
were classified into DP, PP, and ER, and the frequencies
of PP + ER were analyzed. The χ2 test and Fisher’s exact
test were performed to compare the vehicle control and
GBT-treated groups [10]. Fisher’s exact test was used to
compare the vehicle and positive control groups. Differ-
ences were regarded as significant at P < 0.05.
Statistical evaluation of the in vivo micronucleus re-
sults was performed using the method of Lovell et al.
[11] with minor modification. Data with heterogeneous
variances were analyzed using Kruskal–Wallis analysis
of variance followed by multiple comparisons using
Dunnett’s test [12]. The significance was accepted when
all of the PCE/(PCE +NCE) ratios were > 0.1. The result
was judged as positive when there was a significant and







6 h treatment (+S9)
0 + 6-18 0.5/0.5
1250 + 6-18 1.0/1.0
2500 + 6-18 1.5/1.0
5000 + 6-18 2.0/1.5
CPA 6 + 6-18 30.0/29.5**
6 h treatment (-S9)
0 - 6-18 0.0/0.0
1250 - 6-18 0.0/0.0
2500 - 6-18 2.5/2.5
5000 - 6-18 0.5/0.5
EMS 800 - 6-18 22.5/22.0**
22 h treatment (-S9)
0 - 22-2 0.0/0.0
1250 - 22-2 0.0/0.0
2500 - 22-2 0.5/0.5
5000 - 22-2 2.0/1.5
EMS 600 - 22-2 31.5/31.5**
**Significantly different from the control at P<0.01.
a) Treatment time-recovery time.frequency of MNPCEs or aberrant metaphases at one or
more dose levels. Differences were regarded as signifi-
cant at P < 0.05.Results
Acute oral toxicity test
No mortality or clinical symptoms of toxicity were ob-
served in males or females in any group during the ob-
servation period of 14 days. The body weight changes
are summarized in Figure 1. In both sexes, the changes
in body weight did not differ significantly between the
group treated with 2000 mg/kg/day of GBT and the
vehicle control group. At the time of the scheduled
autopsy, there were no abnormal observations of the
internal organs including the lung, heart, thymus,
stomach, liver, adrenals, and spleen in the males or
females given 2000 mg/kg/day of GBT.Bacterial reverse mutation assay (Ames test)
No positive mutagenic response was observed in any of
the S. typhimurium or E. coli strains tested compared
with the concurrent vehicle control groups regardless of
the presence (Figure 2A) or absence (Figure 2B) of the
S9 mixture. The positive controls showed significantly
increased numbers of revertant colonies, indicating that









1.0/1.0 3.0 + 0.0 100
2.0/2.0 0.5 + 0.0 96
2.0/1.5 1.0 + 0.0 96
2.5/2.0 2.0 + 0.0 85
44.0/43.5 1.0 + 0.0 62
0.0/0.0 1.0 + 0.0 100
0.0/0.0 1.0 + 0.0 94
2.5/2.5 1.0 + 0.0 92
1.0/1.0 2.0 + 0.0 83
34.0/33.0 0.5 + 0.0 63
0.0/0.0 1.0 + 0.0 100
0.0/0.0 1.5 + 0.0 94
1.0/1.0 0.5 + 0.0 89
3.5/3.0 1.0 + 0.0 80
46.0/46.0 1.0 + 0.0 54
Table 3 Body weight changes of Micronucleus test in mice following administration of Guibi-Tang (GBT) extract
Group Vehicle control GBT GBT GBT Positive control
Dose (mg/kg) 0 500 1000 2000 70
Day 1 (Mean ± S.D) 34.6 ± 0.79 34.7 ± 1.34 34.8 ± 1.14 35.1 ± 0.57 35.5 ± 0.63
Day 2 (Mean ± S.D) 34.9 ± 1.42 35.2 ± 1.21 35.2 ± 1.19 35.3 ± 0.96 35.3 ± 0.40
Day 3 (Mean ± S.D) 34.8 ± 1.04 35.5 ± 1.11 35.2 ± 0.72 35.0 ± 0.69 34.5 ± 0.67
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According to our preliminary study (data not shown),
GBT neither inhibited cell growth nor killed CHL cells.
We determined the concentration range that was most
compatible with a good cell-proliferating ability and that
produced a sufficient number of metaphases for the
confirmatory assay. Therefore, we used 5000 μg/mL as
the highest exposure level and serial dilutions for fur-
ther dose–response tests.
There were no observable increases in the frequency of
metaphases with aberrant chromosomes at 6 h or 22 h
with or without the S9 mixture in the GBT-treated group
compared with the vehicle control group (Table 2).
Micronucleus test
No abnormal changes were observed in the general
appearance or body weight between the first and final
administrations in the vehicle control group, positive
control group, or the groups treated with 500, 1000,
or 2000 mg/kg/day of GBT (Table 3). The number of
MNPCEs/2000 PCEs and PCE/(PCE + NCE) did not
increase significantly in the groups treated with GBT at
500, 1000, or 2000 mg/kg/day (Table 4). There was signifi-
cant increase in the number of MNPCE/2000PCEs in the
positive control group, indicating that the present study
was preformed under acceptable experimental conditions.
Discussion
Despite the frequent use of medicinal plants, few scientific
studies have been undertaken to determine the safety of
traditional medicinal herbs. To determine the safety of
medicines and plant products intended for human con-
sumption, systematic toxicological studies must be per-
formed using various experimental models to predict the
toxicity and to set the criteria for selecting a safe dose in
humans. Genotoxicity tests have been used mainly for the
prediction of genotoxicity and carcinogenicity of chemicalsTable 4 Micronucleus test in mice following a single oral dose
Group Vehicle control GBT
Dose (mg/kg) 0 500
MNPCE/2000PCEs (Mean ± S.D) 0.33 ± 0.58 1.67 ± 1.15
PCE/(PCE+NCE) (Mean ± S.D) 0.48 ± 0.05 0.53 ± 0.07
Number of animals 3 3
MNPCE: PCE with one or more micronuclei; PCE: Polychromatic erythrocyte; NCE: No
*Significantly different from the control at p<0.05.because compounds that are positive in these tests have
carcinogenic and/or mutagenic potential in humans
[13-15]. However, most commonly used herbal formulas
have no indications of quality, safety, and efficacy.
Guibi-tang is a traditional Korean medicinal formula that
has been used to treat amnesia and memory for several
hundred years. However, its toxicity study remains un-
clear. Therefore, in the present study we evaluate the po-
tential genotoxicity of GBT, we performed tests to detect
chromosome aberrations in CHL cells, a bacterial reverse
mutation test using the S. typhimurium/E. coli incorpor-
ation assay (Ames test), and an in vivo micronucleus test.
The Ames test uses amino acid-requiring strains of
S. typhimurium and E. coli to detect point mutations
involving substitution, addition, or deletions of one or
more DNA base pairs [5]. We found no positive mutagenic
responses to GBT in any of the tester strains compared
with the concurrent vehicle control groups both with and
without application of the S9 mixture. This is a widely ac-
cepted short-term assay to identify substances that can
produce genetic damage leading to gene mutations [16].
Chromosome aberrations are the classical genotoxic
response to tumor initiation and development processes
[17,18]. The purpose of the in vitro chromosome aberra-
tion test is to identify agents that cause structural
chromosome aberrations in cultured mammalian cells
[19,20]. CHL cells [21] were selected as the test system
because they are sensitive to mutagens, their low
chromosome number facilitates scoring, and they can be
used for repeated measurements. In the present study,
the results of the chromosome aberration assay demon-
strated clearly that there were no significant increases in
the number of metaphases with structural aberrations at
any dose of GBT in the presence or absence of the meta-
bolic activation system in CHL cells.
The micronucleus test detects mutagenic substances,
thus altering the equitable distribution of chromosomesof Guibi-Tang (GBT) extract
GBT GBT Positive control (cyclophosphamide)
1000 2000 70
1.00 ± 1.00 0.33 ± 0.58 62.33* ± 10.21
0.50 ± 0.08 0.53 ± 0.05 0.46 ± 0.03
3 3 3
rmochromatic erythrocyte.
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male mice showed no significant increases in the fre-
quency of micronuclei at any dose of GBT (500, 1000,
or 2000 mg/kg/day) compared with the vehicle control
group.
Conclusion
In conclusion, GBT had no genotoxic effects in various
tests involving bacteria and mammals, suggesting that
GBT may not cause mutations in bacterial systems or
chromosome or DNA damage in vitro and in vivo. Fur-
ther detailed experiments are needed to identify whether
GBT contains any genotoxic components and, if so, the
underlying mechanism(s).
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